These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21385901)

  • 21. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
    Deng Q; Wang Q; Zong WY; Zheng DL; Wen YX; Wang KS; Teng XM; Zhang X; Huang J; Han ZG
    Cancer Res; 2010 Jan; 70(2):782-91. PubMed ID: 20068156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.
    Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP
    Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells.
    Xie L; Qin W; Li J; He X; Zhang H; Yao G; Shu H; Yao M; Wan D; Gu J
    Oncol Rep; 2007 Mar; 17(3):605-10. PubMed ID: 17273740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiam1 is associated with hepatocellular carcinoma metastasis.
    Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
    Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
    Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
    Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma].
    Huang JZ; Xia SS; Ye QF; Jiang HY
    Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
    Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
    Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.
    Yan X; Chua MS; Sun H; So S
    Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
    Ma W; Wong CC; Tung EK; Wong CM; Ng IO
    Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF; Ng IO
    Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
    Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
    Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
    Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
    Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of growth factor receptor bound protein 7 in hepatocellular carcinoma.
    Itoh S; Taketomi A; Tanaka S; Harimoto N; Yamashita Y; Aishima S; Maeda T; Shirabe K; Shimada M; Maehara Y
    Mol Cancer Res; 2007 Jul; 5(7):667-73. PubMed ID: 17634422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.